title: Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study.
authors.affiliation: NIHR Moorfields Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation, Trust and UCL Institute of Ophthalmology, London, UK.
authors.forename: Adnan
authors.initials: A
authors.lastname: Tufail
authors.forename: Nirodhini
authors.initials: N
authors.lastname: Narendran
authors.forename: Praveen J
authors.initials: PJ
authors.lastname: Patel
authors.forename: Sobha
authors.initials: S
authors.lastname: Sivaprasad
authors.forename: Winfried
authors.initials: W
authors.lastname: Amoaku
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Browning
authors.forename: Olayinka
authors.initials: O
authors.lastname: Osoba
authors.forename: Richard
authors.initials: R
authors.lastname: Gale
authors.forename: Sheena
authors.initials: S
authors.lastname: George
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Lotery
authors.forename: Mohammed
authors.initials: M
authors.lastname: Majid
authors.forename: Martin
authors.initials: M
authors.lastname: McKibbin
authors.forename: Geeta
authors.initials: G
authors.lastname: Menon
authors.forename: Christopher
authors.initials: C
authors.lastname: Andrews
authors.forename: Christopher
authors.initials: C
authors.lastname: Brittain
authors.forename: Aaron
authors.initials: A
authors.lastname: Osborne
authors.forename: Yit
authors.initials: Y
authors.lastname: Yang
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D047728:Myopia, Degenerative / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011446:Prospective Studies; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab